Alb-CreERT2

Nomenclature

B6.129S-Albtm1.1(CreERT2)Smoc

Cat. NO.

NM-KI-00002

Strain State

Repository Live

Export PDF

Gene Summary

Gene Symbol
ALB

Model Description

Exons 1-7 were replaced by CreERT2 and a loxp neo casette. The KI mice have a tamoxifen-inducible cre-mediated recombination system.This strain has removed the Neo screening gene.
Research Application:cre-mediated recombination system

Validation Data

alb-creERT2-1.png

Fig1 X-gal staining of liver slides of Alb-CreERT2 and LacZ positive mouse before and after tamoxifen injection. 

alb-creERT2-2.png

Fig2  Immunofluorescence analysis of liver using anti-Alb(Green) and anti-LacZ(Red) antibodies showed that Cre is expressed in most hepatocytes.

alb-creERT2-3.png

Fig3  Blood biochemical assay of Alb-CreERT2 male and female mice. Alb-CreERT2 mice do not display any liver functional abnormalities.



You may also like

Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute

On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.

Learn more
Customizing Mouse Models: Delivering in 100 Days to Speed Up Your Research!

At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.

Learn more